FI20020078A0 - Immuunijõrjestelmõn stimulointi polydextroosilla - Google Patents

Immuunijõrjestelmõn stimulointi polydextroosilla

Info

Publication number
FI20020078A0
FI20020078A0 FI20020078A FI20020078A FI20020078A0 FI 20020078 A0 FI20020078 A0 FI 20020078A0 FI 20020078 A FI20020078 A FI 20020078A FI 20020078 A FI20020078 A FI 20020078A FI 20020078 A0 FI20020078 A0 FI 20020078A0
Authority
FI
Finland
Prior art keywords
polydextrose
stimulation
immune system
immune
Prior art date
Application number
FI20020078A
Other languages
English (en)
Swedish (sv)
Other versions
FI20020078A (fi
Inventor
Nina Rautonen
Juha Apajalahti
Kirsti Tiihonen
Original Assignee
Danisco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco filed Critical Danisco
Priority to FI20020078A priority Critical patent/FI20020078A/fi
Publication of FI20020078A0 publication Critical patent/FI20020078A0/fi
Priority to CA2473209A priority patent/CA2473209C/en
Priority to JP2003559496A priority patent/JP4793533B2/ja
Priority to EP02799071.2A priority patent/EP1465505B1/en
Priority to NZ534246A priority patent/NZ534246A/en
Priority to KR1020047011033A priority patent/KR101007512B1/ko
Priority to AU2002364298A priority patent/AU2002364298B2/en
Priority to ES02799071.2T priority patent/ES2562022T3/es
Priority to PCT/EP2002/014719 priority patent/WO2003059333A2/en
Priority to US10/341,748 priority patent/US20030157146A1/en
Publication of FI20020078A publication Critical patent/FI20020078A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI20020078A 2002-01-15 2002-01-15 Immuunijärjestelmän stimulointi polydextroosilla FI20020078A (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20020078A FI20020078A (fi) 2002-01-15 2002-01-15 Immuunijärjestelmän stimulointi polydextroosilla
PCT/EP2002/014719 WO2003059333A2 (en) 2002-01-15 2002-12-23 Stimulation of the immune system with polydextrose
NZ534246A NZ534246A (en) 2002-01-15 2002-12-23 Stimulation of the immune system with polydextrose
JP2003559496A JP4793533B2 (ja) 2002-01-15 2002-12-23 ポリデキストロースでの免疫系の刺激
EP02799071.2A EP1465505B1 (en) 2002-01-15 2002-12-23 Stimulation of the immune system with polydextrose
CA2473209A CA2473209C (en) 2002-01-15 2002-12-23 Stimulation of the immune system with polydextrose
KR1020047011033A KR101007512B1 (ko) 2002-01-15 2002-12-23 폴리덱스트로스를 사용한 면역계의 자극
AU2002364298A AU2002364298B2 (en) 2002-01-15 2002-12-23 Stimulation of the immune system with polydextrose
ES02799071.2T ES2562022T3 (es) 2002-01-15 2002-12-23 Estimulación del sistema inmunitario con polidextrosa
US10/341,748 US20030157146A1 (en) 2002-01-15 2003-01-14 Stimulation of the immune system with polydextrose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20020078A FI20020078A (fi) 2002-01-15 2002-01-15 Immuunijärjestelmän stimulointi polydextroosilla

Publications (2)

Publication Number Publication Date
FI20020078A0 true FI20020078A0 (fi) 2002-01-15
FI20020078A FI20020078A (fi) 2003-07-16

Family

ID=8562798

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020078A FI20020078A (fi) 2002-01-15 2002-01-15 Immuunijärjestelmän stimulointi polydextroosilla

Country Status (10)

Country Link
US (1) US20030157146A1 (fi)
EP (1) EP1465505B1 (fi)
JP (1) JP4793533B2 (fi)
KR (1) KR101007512B1 (fi)
AU (1) AU2002364298B2 (fi)
CA (1) CA2473209C (fi)
ES (1) ES2562022T3 (fi)
FI (1) FI20020078A (fi)
NZ (1) NZ534246A (fi)
WO (1) WO2003059333A2 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002256093A1 (en) * 2001-04-09 2002-10-21 Danisco Usa, Inc. Bulking agents as satiety agents
JP2004049093A (ja) * 2002-07-18 2004-02-19 Meiji Milk Prod Co Ltd 腸内酪酸上昇食品組成物および医薬品
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
EP1629730A1 (en) * 2004-08-12 2006-03-01 First-to-Market N.V. Functional sugar replacement
JP4945554B2 (ja) * 2005-04-28 2012-06-06 ヒタチ ケミカル リサーチ センター インコーポレイテッド 食物サプリメントに対する個体変動評価のモデルとしての全血におけるｅｘｖｉｖｏ遺伝子発現
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
EP1964931B1 (en) 2005-06-08 2010-12-29 Hitachi Chemical Research Center, Inc. Method for predicting immune response to neoplastic disease based on mRNA expression profile in neoplastic cells and stimulated leukocytes
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US20070048344A1 (en) * 2005-08-31 2007-03-01 Ali Yahiaoui Antimicrobial composition
US20070048358A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial substrates
US20070048356A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial treatment of nonwoven materials for infection control
ATE518011T1 (de) 2006-04-07 2011-08-15 Hitachi Chemical Co Ltd Erhöhte expression von t- zellenrezeptorvermittelter tumornekrosefaktorsuperfamilie und chemokin-mrna in peripheren blut leukozyten bei patienten mit morbus& xa;crohn
WO2009070442A2 (en) 2007-11-14 2009-06-04 Hitachi Chemical Co. Ltd. Fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes
GB2448106B (en) * 2007-02-23 2011-10-26 Cadbury Schweppes Plc Candy compositon with fibre-containing centrefill
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
FR2974512B1 (fr) * 2011-04-28 2013-11-08 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant du maltitol
BR112014010660A2 (pt) * 2011-11-04 2017-05-09 Gen Mills Inc métodos e composições para modular bactéria gastrointestinal
AU2014241162A1 (en) 2013-03-27 2015-10-22 Cedars-Sinai Medical Center Mitigation and reversal of fibrosis and inflammation by inhibition of TL1A function and related signaling pathways
US10316083B2 (en) 2013-07-19 2019-06-11 Cedars-Sinai Medical Center Signature of TL1A (TNFSF15) signaling pathway
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
JP7351472B2 (ja) * 2018-10-12 2023-09-27 日本食品化工株式会社 ＩｇＡ分泌促進用組成物
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
US20210195929A1 (en) * 2019-12-31 2021-07-01 Kraft Foods Group Brands Llc No sugar added multilayer edible products comprising a center and a barrier layer

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2436967A (en) * 1942-04-01 1948-03-02 Corn Prod Refining Co Polymerization of sugars
US2719179A (en) * 1951-01-25 1955-09-27 Mora Peter Tibor Branched-chain carbohydrate polymers and their preparation
US3766165A (en) * 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
FI73121C (fi) * 1985-08-08 1987-09-10 Valio Meijerien Vaextbefraemjande foder och tillsatsaemne foer anvaendning daeri.
US4659338A (en) * 1985-08-16 1987-04-21 The Lubrizol Corporation Fuel compositions for lessening valve seat recession
JPS62220169A (ja) * 1986-03-18 1987-09-28 Yakult Honsha Co Ltd 流動性食品
US5013722A (en) * 1986-06-06 1991-05-07 Hoffmann-Laroche Inc. Cholecystokinin analogs for controlling appetite
US4789664A (en) * 1986-12-19 1988-12-06 The Procter & Gamble Company Food compositions with superior blood cholesterol lowering properties
US4808701A (en) * 1987-03-30 1989-02-28 Hoffmann-La Roche Inc. Cyclic peptides having appetite regulating activity
US4965354A (en) * 1988-02-26 1990-10-23 Taito Company, Ltd. Process for producing a condensed polysaccharide
JP2802077B2 (ja) * 1988-09-07 1998-09-21 昭和産業株式会社 飲食品
US5098730A (en) * 1988-11-14 1992-03-24 Cultor Ltd. Dietetic sweetening composition
US5667593A (en) * 1989-01-26 1997-09-16 Cultor Ltd. Modified polydextrose and process therefor
US5051500A (en) * 1989-08-11 1991-09-24 A. E. Staley Manufacturing Company Method of preparing a randomly-bonded polysaccharide
US5378491A (en) * 1990-02-20 1995-01-03 A. E. Staley Manufacturing Co. Method of preparing a starch hydrolysate, an aqueous starch hydrolysate dispersion, method of preparing a food containing a starch hydrolysate, and a food formulation containing a starch hydrolysate
SE9003713L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande dietfiberkomposition
KR100226394B1 (ko) * 1991-02-20 1999-10-15 디. 제이. 우드, 스피겔 알렌 제이 환원된 폴리덱스트로즈
US5336486A (en) * 1991-03-28 1994-08-09 Theratech, Inc. Appetite control method
FR2688800B1 (fr) * 1992-03-19 1995-06-16 Roquette Freres Procede de preparation de polysaccharides peu digestibles, eventuellement hydrogenes.
JP2654529B2 (ja) * 1992-03-27 1997-09-17 大塚製薬株式会社 健康飲料組成物
US5273754A (en) * 1992-03-27 1993-12-28 Mann Morris A Appetite suppressant composition and method relating thereto
CA2110993C (en) * 1992-04-10 2002-02-05 Akihisa Takaichi Food composition for inhibiting the formation of an intestinal putrefactive product
US5322697A (en) * 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
FR2697023B1 (fr) * 1992-10-16 1994-12-30 Roquette Freres Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère .
US5439893A (en) * 1993-05-26 1995-08-08 University Of Montana Methods for the treatment and prevention of diarrhea
US5728225A (en) * 1993-07-26 1998-03-17 Roquette Freres Viscous liquid compositions of xylitol and a process for preparing them
JP3310738B2 (ja) * 1993-11-10 2002-08-05 株式会社ロッテ 低カロリーチョコレート
FR2712891B1 (fr) * 1993-11-22 1996-02-02 Roquette Freres Procédé de purification d'un polymère soluble hypocalorique du glucose et produit ainsi obtenu.
US5843921A (en) * 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
FR2726829B1 (fr) * 1994-11-10 1997-01-17 Roquette Freres Composition de polyols, son procede de preparation et ses applications
US5527554A (en) * 1995-06-02 1996-06-18 Xyrofin Oy Bulk sweetener for frozen desserts
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
JP3426440B2 (ja) * 1996-01-18 2003-07-14 株式会社ロッテ 新規な脱乳糖乳・脱乳糖粉乳およびこれを含有する飲食物ならびに脱乳糖乳および脱乳糖粉乳の製造方法
ES2184847T5 (es) * 1996-07-31 2007-03-01 "RAFFINERIE TIRLEMONTOISE", SOCIETE ANONYME Polvos lacticos que contienen fructano y/o polidextrosa, procedimiento para su preparacion y su uso.
JP2000143519A (ja) * 1998-11-04 2000-05-23 Kao Corp 腸内低級脂肪酸生成促進剤
JP2001064181A (ja) * 1999-08-27 2001-03-13 Otsuka Pharmaceut Co Ltd 免疫賦活組成物
US6677318B1 (en) * 2000-09-05 2004-01-13 Beisel Guenther Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
AU2002256093A1 (en) * 2001-04-09 2002-10-21 Danisco Usa, Inc. Bulking agents as satiety agents
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset

Also Published As

Publication number Publication date
JP2005523250A (ja) 2005-08-04
FI20020078A (fi) 2003-07-16
KR101007512B1 (ko) 2011-01-14
CA2473209A1 (en) 2003-07-24
WO2003059333A3 (en) 2003-12-11
ES2562022T3 (es) 2016-03-02
AU2002364298A1 (en) 2003-07-30
NZ534246A (en) 2008-09-26
AU2002364298B2 (en) 2009-01-15
EP1465505B1 (en) 2015-11-18
US20030157146A1 (en) 2003-08-21
WO2003059333A2 (en) 2003-07-24
JP4793533B2 (ja) 2011-10-12
CA2473209C (en) 2011-09-20
EP1465505A2 (en) 2004-10-13
KR20040103914A (ko) 2004-12-09

Similar Documents

Publication Publication Date Title
FI20020078A0 (fi) Immuunijõrjestelmõn stimulointi polydextroosilla
NO20053678D0 (no) Kombinasjonsterapi for behandling av immuninflammatoriske forstyrrelser
CY2015025I2 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
NO20050136D0 (no) Fremgangsmate for fremstilling av mikropartikler
DE60331470D1 (de) Av-system
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
DK1549242T3 (da) Implanterbar sensor
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
DE60239766D1 (de) Wärmebehandlungssystem
DE602004020655D1 (de) Aminosubstituierte ethylaminoagonisten des beta2-adrenergen rezeptors
DE60313272D1 (de) Lösbares Befestigungssystem
DE60309170D1 (de) Telemetriesystem
DE50210973D1 (de) Meltblown-Anlage
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
NO20040497L (no) Amidinderivater for behandling av amyloidose
AU2003260818A8 (en) Treatment of immune system dysfunction
PL374885A1 (en) Vitamin-containing system for stabilising the immune response of animals
DE60229887D1 (de) Oberflächenbehandlungssystem
SE0203585L (sv) Fästelement
UA8116S (uk) Камера терапевтична індивідуальна
NO20033160D0 (no) Anordning for behandling av gravann
ITMI20020052A0 (it) Procedimento per l'idrolisi selettiva di nucleosidi poliesteri
EP1474151A4 (en) METHODS OF TREATING CHRONIC IMMUNE DISEASE

Legal Events

Date Code Title Description
FD Application lapsed